Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Highlights from IGILUC 2019

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019

ALK-positive NSCLC: Treatments and latest developments

Prof Tony Mok - Chinese University of Hong Kong, Hong Kong
ALK-positive NSCLC: Treatments and latest developments ( Prof Tony Mok - Chinese University of Hong Kong, Hong Kong )
29 Apr 2019

ALK-positive NSCLC: Current landscape

Dr Antonio Passaro and Prof Rafal Dziadziuszko
ALK-positive NSCLC: Current landscape ( Dr Antonio Passaro and Prof Rafal Dziadziuszko )
29 Apr 2019

How the WIN consortium achieves its goals

Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA
How the WIN consortium achieves its goals ( Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA )
25 Apr 2019

The translational element of the WIN consortium

Dr Brian Leyland-Jones - WIN Head of Fundraising Committee
The translational element of the WIN consortium ( Dr Brian Leyland-Jones - WIN Head of Fundraising Committee )
25 Apr 2019

Making oncology global with the WIN consortium

Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Making oncology global with the WIN consortium ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Apr 2019

An overview of the WIN consortium

Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA
An overview of the WIN consortium ( Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA )
25 Apr 2019

The WIN symposium 2019

Prof Razelle Kurzrock - University of California San Diego, San Diego, USA
The WIN symposium 2019 ( Prof Razelle Kurzrock - University of California San Diego, San Diego, USA )
25 Apr 2019

Latest data from KEYNOTE 42: Pembrolizumab vs chemotherapy in treatment-naive patients (pts) with PD-L1 advanced NSCLC

Prof Tony Mok - Chinese University of Hong Kong, Hong Kong
Latest data from KEYNOTE 42: Pembrolizumab vs chemotherapy in treatment-naive patients (pts) with PD-L1 advanced NSCLC ( Prof Tony Mok - Chinese University of Hong Kong, Hong Kong )
18 Apr 2019

The role of afatinib in patients with EGFR NSCLC

Dr Antonio Passaro - European Institute of Oncology, Milan, Italy
The role of afatinib in patients with EGFR NSCLC ( Dr Antonio Passaro - European Institute of Oncology, Milan, Italy )
18 Apr 2019

5' UTR mutations in prostate cancer

Dr Yiting Lim, Fred Hutchinson Cancer Research Center, Seattle, USA
5' UTR mutations in prostate cancer ( Dr Yiting Lim, Fred Hutchinson Cancer Research Center, Seattle, USA )
15 Apr 2019

Clinical trials in Africa: Bench to bedside

Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria
Clinical trials in Africa: Bench to bedside ( Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria )
10 Apr 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation